Mr. Vijchu Chantatub During 24 - 29 October 2018 and 13 November 2018, Mr. Vijchu Chantatub as a private fund manager, managed a private fund without honesty and care to preserve the interests of the
1 NO. NCH 024/2562 July 11, 2019 Subject : Notice of setting up a new subsidiary under joint venture agreement to cover intermediate care and wellness business Attn. : Director and Manager The Stock
) Name Year Receive Date Details EKACHAI MEDICAL CARE PUBLIC COMPANY LIMITED 2018 02/04/2019 EKACHAI MEDICAL CARE PUBLIC COMPANY LIMITED 2017 30/03/2018 EKACHAI MEDICAL CARE PUBLIC COMPANY LIMITED 2016 31
) Name Year Receive Date Details EKACHAI MEDICAL CARE PUBLIC COMPANY LIMITED 2020 02/04/2021 EKACHAI MEDICAL CARE PUBLIC COMPANY LIMITED 2019 30/03/2020 EKACHAI MEDICAL CARE PUBLIC COMPANY LIMITED 2018 02
of Company Secretary, the Establishment of New Subsidiary and Subsidiary to Purchase Drug Care Company Limited (Revise no. 2) 10/11/2021 09:27 Notification of the resignation of Chairman of the Audit
THB 342 million), driven by growth in both beverage and personal care businesses. Beverage segment grew from all major categories, including flagship brand M-150, herbal-variant Som In-Sum and Chalarm
, including flagship brand M-150, herbal-variant Som In-Sum and functional drinks’ rising star C-Vitt. Personal care segment showed growth of 7.2% YoY mainly from a continued success of Babi Mild, along with
Domestic Beverage sales including C-Vitt & Calpis** grew by 2.7%. Total Personal Care showed 11.7%, driven by growth from international businesses in CLM (+42.8% YoY). Total revenue from sales reported at
, biodiversity conservation, and pollution prevention and control) rather than four key areas of concern as previously. It notes that international and national initiatives to produce taxonomies may give further
Stock Exchange of Thailand Ekachai Medical Care Public Company Limited (the “Company”) would like to clarify on the operating results for the second quarter of 2019 at the end of 30th June 2019 as follows